Literature DB >> 18954708

Calcifications are potential surrogates for prostate localization in image-guided radiotherapy.

Grace G Zeng1, Tom S McGowan, Tessa M Larsen, Lisa M Bruce, Natasha K Moran, Jonathan R Tsao, Miller S MacPherson.   

Abstract

PURPOSE: To investigate the feasibility of using calcifications as surrogates for the prostate position during cone-beam computed tomography (CBCT) image-guided radiotherapy. METHODS AND MATERIALS: The twice-weekly CBCT images taken during the treatment course of 4 patients were retrospectively studied for the stability of the calcifications. The geometric center of three fiducial markers was used as the reference. The planning CT images of 131 prostate patients recently treated with external beam radiotherapy at our center were reviewed to estimate the calcification occurrence rate. Analysis was conducted using the Varian Eclipse treatment planning system. Two patients were treated using prostate calcifications as the landmark in on-line registration. Both the Varian standard and the low-dose CBCT modes were used for imaging.
RESULTS: The calcifications were found to be stable during the treatment course. At the 95% confidence interval, the difference between the distance from an identified calcification to the fiducial markers on CBCT and the distance on the planning CT scans was 0.2 +/- 2.0 mm, 0.8 +/- 2.2 mm, and 0.4 +/- 2.4 mm in the left-right, anteroposterior, and superoinferior direction, respectively. Of the 131 patients, 46 (35%) had well-defined calcifications either inside the prostate or near the borders. Our experience in treating the first 2 patients demonstrated that the calcifications are easily distinguished on low-dose scans and that calcification registration can be precisely performed.
CONCLUSION: The results of our study have shown that calcifications can be reliable markers of prostate position and allow for precise image guidance with a low-imaging dose. With this approach, potentially about one-third of prostate patients could benefit from precise image guidance without the invasive use of markers.

Entities:  

Mesh:

Year:  2008        PMID: 18954708     DOI: 10.1016/j.ijrobp.2008.07.021

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

Review 1.  Fiducial marker guided prostate radiotherapy: a review.

Authors:  Angela G M O'Neill; Suneil Jain; Alan R Hounsell; Joe M O'Sullivan
Journal:  Br J Radiol       Date:  2016-09-23       Impact factor: 3.039

2.  Clinical evaluation of soft tissue organ boundary visualization on cone-beam computed tomographic imaging.

Authors:  Elisabeth Weiss; Jian Wu; William Sleeman; Joshua Bryant; Priya Mitra; Michael Myers; Tatjana Ivanova; Nitai Mukhopadhyay; Viswanathan Ramakrishnan; Martin Murphy; Jeffrey Williamson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-09       Impact factor: 7.038

3.  Prostate deformation from inflatable rectal probe cover and dosimetric effects in prostate seed implant brachytherapy.

Authors:  Jun Lian; Yeqin Shao; Larry D Potter; Ronald C Chen; Jordan A Holmes; Eleanor A Pryser; Jie Shen; Dinggang Shen; Andrew Z Wang
Journal:  Med Phys       Date:  2016-12       Impact factor: 4.071

4.  Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer.

Authors:  Filippo Alongi; Rosario Mazzola; Alba Fiorentino; Stefanie Corradini; Dario Aiello; Vanessa Figlia; Fabiana Gregucci; Riccardo Ballario; Stefano Cavalleri; Ruggero Ruggieri
Journal:  Strahlenther Onkol       Date:  2018-07-12       Impact factor: 3.621

5.  Calcium Phosphate Cement Paste Injection as a Fiducial Marker of Cervical Cancer.

Authors:  Ichiro Ogino; Masakazu Kitagawa; Shigenobu Watanabe; Hiroshi Yoshida; Masaharu Hata
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

6.  Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study.

Authors:  Filippo Alongi; Luca Cozzi; Stefano Arcangeli; Cristina Iftode; Tiziana Comito; Elisa Villa; Francesca Lobefalo; Pierina Navarria; Giacomo Reggiori; Pietro Mancosu; Elena Clerici; Antonella Fogliata; Stefano Tomatis; Gianluigi Taverna; Pierpaolo Graziotti; Marta Scorsetti
Journal:  Radiat Oncol       Date:  2013-07-08       Impact factor: 3.481

7.  Multiparametric prostate MRI-based intensity-modulated radiation therapy guided by prostatic calcifications.

Authors:  Johnny Kao; Pawel Karwowski; Jeffrey Pettit; Austin Kevin Barney; Christopher Atalla
Journal:  Br J Radiol       Date:  2020-08-26       Impact factor: 3.039

8.  Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients.

Authors:  Luca Nicosia; Rosario Mazzola; Michele Rigo; Vanessa Figlia; Niccolò Giaj-Levra; Giuseppe Napoli; Francesco Ricchetti; Stefanie Corradini; Ruggero Ruggieri; Filippo Alongi
Journal:  J Cancer Res Clin Oncol       Date:  2019-07-19       Impact factor: 4.553

9.  Assessment of interfractional prostate motion in patients immobilized in the prone position using a thermoplastic shell.

Authors:  Itaru Ikeda; Takashi Mizowaki; Yohei Sawada; Manabu Nakata; Yoshiki Norihisa; Masakazu Ogura; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2013-07-16       Impact factor: 2.724

10.  Mask-Adapted Background Field Removal for Artifact Reduction in Quantitative Susceptibility Mapping of the Prostate.

Authors:  Sina Straub; Julian Emmerich; Heinz-Peter Schlemmer; Klaus H Maier-Hein; Mark E Ladd; Matthias C Röthke; David Bonekamp; Frederik B Laun
Journal:  Tomography       Date:  2017-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.